Next Issue
Volume 3, November
Previous Issue
Volume 3, September
 
 

COVID, Volume 3, Issue 10 (October 2023) – 9 articles

Cover Story (view full-size image): Given the observed variability in inflammatory responses to SARS-CoV-2 infections, we have developed an in vitro model system (based on monocytes and macrophages) that yielded insights regarding the impact of rs2228145, a clinically relevant polymorphism within a key inflammatory gene in the body’s response to SARS-CoV-2 infections: the interleukin-6 receptor (IL-6R) gene. The treatment of monocytes and macrophages with SARS-CoV-2 spike-protein induced pro-inflammatory IL-6/IL-6R signaling responses whose severity was influenced by the monocyte–macrophage rs2228145 genotype. These findings may aid the future management/treatment of COVID-19 and long COVID, as rs2228145 genotyping may allow the identification of those at risk of severe and/or prolonged symptoms following SARS-COV-2 infection. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
17 pages, 863 KiB  
Article
A Qualitative Analysis of Older Adults’ Cognitive Appraisal in Coping during the COVID-19 Pandemic: The Role of Social Capital
by Linying Dong, Alexandra Katsiris, Mariah Lecompte, Cassandra Skrotzki and Lixia Yang
COVID 2023, 3(10), 1622-1638; https://doi.org/10.3390/covid3100111 - 19 Oct 2023
Cited by 1 | Viewed by 1657
Abstract
The ability to adaptively cope with the challenges of stressful events such as the COVID-19 pandemic is crucial for healthy aging. One effective coping strategy is social coping in which social networks are tapped for support. However, our review of the current literature [...] Read more.
The ability to adaptively cope with the challenges of stressful events such as the COVID-19 pandemic is crucial for healthy aging. One effective coping strategy is social coping in which social networks are tapped for support. However, our review of the current literature on older adults’ coping abilities reveals two shortcomings: (1) a lack of consideration of a specific context and (2) an inadequate amount of attention paid to the different types of social networks in the cognitive appraisal process. As coping is a process in which older adults undergo the cognitive appraisal process to identify appropriate coping strategies, the shortcomings result in an incomplete understanding of older adults’ coping efforts and impair the development of effective community and intervention programs to improve older adults’ well-being. To fill this gap, drawing on the Transactional Model of Stress and Coping and the Social Capital Theory, we conducted 22 interviews with older adults who experienced lockdown measures during COVID-19. Our in-depth qualitative analysis shows the different roles played by bonding and bridging social capital in the cognitive appraisal process and illustrates the influence of a specific context on cognitive appraisals and subsequent coping efforts. Our findings provide significant contributions to theories regarding coping and social capital, as well as practices and policies for improving the well-being of older adults. Full article
(This article belongs to the Special Issue COVID and Post-COVID: The Psychological and Social Impact of COVID-19)
Show Figures

Figure 1

10 pages, 256 KiB  
Article
Housing Status and COVID-19 Prevention Recommendations among People Who Use Drugs
by Izza Zaidi, Ashly E. Jordan, Lauren Jessell, Leonardo Dominguez Gomez, Alex Harocopos and Michelle Nolan
COVID 2023, 3(10), 1612-1621; https://doi.org/10.3390/covid3100110 - 17 Oct 2023
Viewed by 1399
Abstract
Housing conditions can increase health risks for people who use opioids (PWUO). Little research documents the influence of housing on PWUO’s ability to practice disease prevention methods. This study examines associations between housing status of PWUO in NYC and their ability to practice [...] Read more.
Housing conditions can increase health risks for people who use opioids (PWUO). Little research documents the influence of housing on PWUO’s ability to practice disease prevention methods. This study examines associations between housing status of PWUO in NYC and their ability to practice COVID-19 prevention recommendations during the initial wave of the pandemic. Participants were recruited via convenience sampling and administered a survey. Eligibility required age ≥18 years, using opioids ≥3times in the prior 30 days, and accessing a health-related service in the prior year. Descriptive and bivariate statistics assessed relationships between housing and the ability to practice social distancing, access soap and running water or hand sanitizer (soap), and access face masks. Multivariable Poisson regression was used to examine relationships between housing and the potential to practice COVID-19 prevention recommendations. The 329 participants were grouped into stable housing (34.3%), unstable/shelter housing (31.9%), and street homeless (33.7%) categories. Street homeless PWUO were significantly less likely to have access to soap and face masks than those stably housed. There were no significant differences between PWUO experiencing unstable and stable housing. PWUO experiencing street homelessness may have had increased vulnerability to COVID-19. Providing low-threshold health-related resources and increasing linkages to housing opportunities could promote health of PWUO experiencing street homelessness during future emergencies. Full article
(This article belongs to the Special Issue COVID and Post-COVID: The Psychological and Social Impact of COVID-19)
11 pages, 290 KiB  
Article
Changes in Lifestyle Habits in Individuals with Diabetes during the COVID-19 Pandemic: The ELSA-Brasil Cohort Study
by William Jones Dartora, Maria Inês Schmidt, Rosane Harter Griep and Bruce B. Duncan
COVID 2023, 3(10), 1601-1611; https://doi.org/10.3390/covid3100109 - 12 Oct 2023
Viewed by 1726
Abstract
The COVID-19 pandemic and society’s response to it may have constrained the ability of those with diabetes to achieve a healthy lifestyle. We conducted a longitudinal study to assess the frequency and magnitude of sedentary habits, physical activity, sleep, alcohol consumption, weight, and [...] Read more.
The COVID-19 pandemic and society’s response to it may have constrained the ability of those with diabetes to achieve a healthy lifestyle. We conducted a longitudinal study to assess the frequency and magnitude of sedentary habits, physical activity, sleep, alcohol consumption, weight, and smoking from July 2020 to February 2021 and compared these levels to those before the pandemic (2017–2019) in 1082 participants of the ELSA-Brasil study with known diabetes. Our results showed that inappropriate sleep duration was common (649, 68.9%) before the pandemic. Many (447, 31.1%) with this problem achieved an adequate sleep duration during the pandemic. Significant increases occurred in time in front of screens (1.3; 95%CI 0.66–2.11 h/day) and time sitting or reclining (1.4, 95%CI 0.8–2.3 h/day). Physical activity decreased (270, 95%CI 243–298 MET-min/wk). Alcohol consumption decreased without statistical significance (−19.6, 95%CI −51.1–11.9 g/w). In general, changes were similar between diabetics and non-diabetics, except that screen time in-creased less (−0.18, −0.35–−0.01 h/day) for those with diabetes. Sleep duration improved, but the frequency of sedentary habits increased, and physical activity decreased during the pandemic. Understanding changes brought on by the pandemic is essential to facilitate the implementation of quality health care for those with diabetes in moments of social stress. Full article
(This article belongs to the Special Issue How COVID-19 and Long COVID Changed Individuals and Communities)
15 pages, 1074 KiB  
Review
SARS-CoV-2: An Update on the Biological Interplay with the Human Host
by Giuseppe Lippi, Fabian Sanchis-Gomar, Camilla Mattiuzzi and Brandon M. Henry
COVID 2023, 3(10), 1586-1600; https://doi.org/10.3390/covid3100108 - 10 Oct 2023
Cited by 2 | Viewed by 1394
Abstract
Coronavirus Disease 2019 (COVID-19) is an infectious respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease, first identified in the Chinese city of Wuhan in November 2019, has since spread worldwide, is the latest human pandemic and has officially [...] Read more.
Coronavirus Disease 2019 (COVID-19) is an infectious respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease, first identified in the Chinese city of Wuhan in November 2019, has since spread worldwide, is the latest human pandemic and has officially infected over 800 million people and has caused nearly seven million deaths to date. Although SARS-CoV-2 belongs to the large family of coronaviruses, it has some unique biological characteristics in its interplay with the human host. Therefore, this narrative review aims to provide an up-to-date overview of the structure of the virus, incubation and shedding in the human host, infectivity and biological evolution over time, as well as the main mechanisms for invading human host cells and replicating within. We also proffer that ongoing epidemiological surveillance of newly emerged variants must always be accompanied by biological studies aimed at deciphering new advantageous traits that may contribute to increasing virulence and pathogenicity, such that the most appropriate strategies for establishing a (relatively) safe coexistence with the human host can be implemented. Full article
Show Figures

Figure 1

15 pages, 304 KiB  
Article
Psychotherapy Incorporating Equine Interaction as a Complementary Therapeutic Intervention for Young Adults in a Residential Treatment Program during the COVID-19 Pandemic
by Katie Holtcamp, Molly C. Nicodemus, Tommy Phillips, David Christiansen, Brian J. Rude, Peter L. Ryan and Karen Galarneau
COVID 2023, 3(10), 1571-1585; https://doi.org/10.3390/covid3100107 - 4 Oct 2023
Cited by 5 | Viewed by 2056
Abstract
Substance use disorder has become an epidemic in the young adult population across the United States, and these numbers rose during the COVID-19 pandemic. Psychotherapy incorporating equine interaction has emerged to show promise in the mental health community as a complementary form of [...] Read more.
Substance use disorder has become an epidemic in the young adult population across the United States, and these numbers rose during the COVID-19 pandemic. Psychotherapy incorporating equine interaction has emerged to show promise in the mental health community as a complementary form of therapy for this age group and offered a viable treatment option during the pandemic due to the outdoor nature of the treatment environment. However, research concerning its use within a residential treatment program was lacking. The objective of this study was to evaluate the efficacy of psychotherapy incorporating equine interaction in a residential treatment program during the COVID-19 pandemic for developing an emotionally safe environment for learning for young adults. Participants (ages 18–25 years) were those in a substance abuse residential treatment program utilizing psychotherapy incorporating equine interaction during the COVID-19 pandemic. Participants were involved in weekly equine therapy for 2–7 weeks. Participants were divided according to length of stay at the residential facility and participation level with equine interactive activities. Assessment of emotional safety and long-term memory development was performed at the beginning and end of the treatment program. The development of memories centered around equine information that was covered during the treatment program. Semantic memory was assessed using a self-reporting knowledge exam and procedural memory was assessed using a skill evaluation. Emotional safety was determined using a self-reporting survey instrument. Paired t-tests determined significant improvement in emotional safety (p = 0.02) and semantic (p = 0.01) and procedural (p = 0.00) memory for all participants by the end of the program. The one-way analysis of variance indicated length of stay and participation level were not significant indicators of emotional safety (length of stay: p = 0.91, participation level: p = 0.98) and semantic (length of stay: p = 0.09, participation level: p = 0.60) and procedural (length of stay: p = 0.25, participation level: p = 0.09) memory development. These results suggest psychotherapy incorporating equine interaction was an efficient complementary therapeutic intervention for developing emotional safety and encouraging learning in a young-adult residential addiction treatment program during the COVID-19 pandemic. Full article
(This article belongs to the Special Issue COVID and Post-COVID: The Psychological and Social Impact of COVID-19)
17 pages, 1976 KiB  
Article
The rs2228145 Variant of the Interleukin-6 Receptor (IL-6R) Gene Impacts on In Vitro Cellular Responses to SARS-CoV-2 VOC B1.1.7 Recombinant Spike Protein
by Saira Sarwar, Rebecca Aicheler, Lee Butcher, Katie Rees, Stephen Potter, Richard Rowlands and Richard Webb
COVID 2023, 3(10), 1554-1570; https://doi.org/10.3390/covid3100106 - 3 Oct 2023
Viewed by 2196
Abstract
Given the variability in inflammatory responses to SARS-CoV-2 infection observed within human populations, we aimed to develop an in vitro model system (based on monocyte-macrophages, a key relevant cell type) that could yield insights regarding the impact of rs2228145, a clinically relevant polymorphism [...] Read more.
Given the variability in inflammatory responses to SARS-CoV-2 infection observed within human populations, we aimed to develop an in vitro model system (based on monocyte-macrophages, a key relevant cell type) that could yield insights regarding the impact of rs2228145, a clinically relevant polymorphism within the coding region of a key inflammatory gene in the body’s response to SARS-CoV-2 infection: the interleukin-6 receptor (IL-6R) gene. Three monocyte-macrophage cell-lines (U937, THP-1, MM6) were shown to exhibit AA, AC and CC rs2228145 genotypes, respectively, and to exhibit an MM6 > THP-1 > U937 pattern regarding basal levels of soluble IL-6R (sIL-6R) release. Similar MM6 > THP-1 > U937 patterns were seen regarding the extents to which (i) circulating levels of the IL-6/sIL-6R ‘active complex’ increased and (ii) phosphorylation of the downstream transcription-factor STAT3 occurred, following treatment with SARS-CoV-2 spike protein (SP). Moreover, a blocking antibody for the ACE-2 entry receptor for SARS-CoV-2 suppressed effects (i) and (ii), suggesting that interaction between SP and ACE-2 is the initial event that triggers IL-6/IL-6R signalling in our system. Production of IL-8 occurred to greater extents in A549 lung epithelial cells treated with tissue-culture supernatants from SP-treated MM6 cultures than SP-treated THP-1 or U937 cultures. Our data indicate that the rs2228145 genotype significantly impacts upon SP-associated IL-6/sIL-6R signalling in vitro, suggesting that it may influence in vivo risk of developing severe COVID-19 and/or long-COVID symptoms following infection by SARS-CoV-2. Thus, the rs2228145 genotype may have potential as a biomarker that differentiates between patients at risk of developing severe and/or prolonged symptoms following infection by SARS-CoV-2 and those who are at less risk. Full article
(This article belongs to the Special Issue Immune Responses in Coronavirus Disease)
Show Figures

Graphical abstract

10 pages, 271 KiB  
Article
Perceived Stress and Coping among University Students Amidst COVID-19 Pandemic
by Coral L. Shuster, Marie C. Tate, Christina T. Schulz, Cheyenne T. Reyes, Megan M. Drohan, Angela G. Astorini, Amy L. Stamates, Manshu Yang and Mark L. Robbins
COVID 2023, 3(10), 1544-1553; https://doi.org/10.3390/covid3100105 - 29 Sep 2023
Cited by 2 | Viewed by 3800
Abstract
University students may have experienced heightened levels of stress during the COVID-19 pandemic; however, less is known about coping mechanisms (i.e., approach and avoidance) that were used to manage such stress. Further, there is a need to identify groups of students who may [...] Read more.
University students may have experienced heightened levels of stress during the COVID-19 pandemic; however, less is known about coping mechanisms (i.e., approach and avoidance) that were used to manage such stress. Further, there is a need to identify groups of students who may have been at elevated risk for stress. The present study examined the association between coping and perceived stress and whether there were differences in stress based on sociodemographic factors and COVID-19-related changes in employment, housing, and income. Data were collected from 150 university students between the ages of 18 and 25 years (M = 20.68; SD = 1.73). Results indicated that those who endorsed more approach coping skills had lower levels of stress and those who endorsed more avoidance coping skills had higher levels of stress. Additionally, females, those who lost income, and non-heterosexual individuals endorsed higher levels of stress. The results demonstrate the importance of targeted discussions with university students regarding stressors and coping mechanisms. Full article
16 pages, 1009 KiB  
Article
Research Staff COVID-19 Pandemic Survey-Results from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network
by Jasreen Kaur Gill, Andrew Bissonette, Aaron A. Cook, Anja Kathrin Jaehne, Jacqueline Day, Sheri Renaud, Gordon Jacobsen, Kristine Nelson, Lori-Ann Kozikowski, Namita Jayaprakash, Jayna Gardner-Gray, Jennifer Swiderek, Cathryn F. Oldmixon, Nancy J. Ringwood, Robert L. Sherwin, Mark D. Williams, Arielle Hodari Gupta, Nicholas J. Johnson, Robert C. Hyzy, Pauline K. Park, Emanuel P. Rivers and on behalf of the National Heart, Lung and Blood Institute PETAL Clinical Trials Networkadd Show full author list remove Hide full author list
COVID 2023, 3(10), 1528-1543; https://doi.org/10.3390/covid3100104 - 23 Sep 2023
Viewed by 1702
Abstract
Objectives: There is a lack of knowledge about the challenges of researchers who continued in-person research during the early phases of the COVID-19 pandemic. Design: Electronic survey assessing work-related exposure to COVID-19, logistical challenges, and procedural changes during the first year of the [...] Read more.
Objectives: There is a lack of knowledge about the challenges of researchers who continued in-person research during the early phases of the COVID-19 pandemic. Design: Electronic survey assessing work-related exposure to COVID-19, logistical challenges, and procedural changes during the first year of the COVID-19 pandemic on clinical research. Setting: National Heart, Lung, and Blood Institute-sponsored Prevention and Early Treatment of Acute Lung Injury Clinical Trial Network Centers. Subjects: Research staff at research Network Sites. Measurements and Main Results: The 37-question survey was completed by 277 individuals from 24 states between 29 September 2020, and 12 December 2020, yielding a response rate of 37.7%. Most respondents (91.5%) indicated that non-COVID-19 research was affected by COVID-19 research studies. In response to the COVID-19 pandemic, 20% of respondents were reassigned to different roles at their institution. Many survey takers were exposed to COVID-19 (56%), with more than 50% of researchers requiring a COVID-19 test and 8% testing positive. The fear of infection was 2.7-times higher compared to pre-COVID-19 times. Shortages of personal protective equipment were encountered by 34% of respondents, primarily due to lack of access to N95 masks, followed by gowns and protective eyewear. Personal protective equipment reallocation from research to clinical use was reported by 31% of respondents. Most of the respondents (88.5%), despite these logistical challenges, indicated their willingness to enroll COVID-19 patients. Conclusions: During the first year of the COVID-19 pandemic, members of the research network were engaged in COVID-19 research despite logistical challenges, limited access to personal protective equipment, and fear of exposure. The research network’s survey experience can inform ongoing policy discussions to create research enterprises that can dexterously refocus research to address the knowledge gaps associated with novel public health emergencies while mitigating the effect of pandemics on existing research projects and research personnel. Full article
(This article belongs to the Special Issue COVID and Post-COVID: The Psychological and Social Impact of COVID-19)
Show Figures

Figure 1

12 pages, 2168 KiB  
Review
Effectiveness of COVID-19 Vaccination on Transmission: A Systematic Review
by Anouk Oordt-Speets, Julia Spinardi, Carlos Mendoza, Jingyan Yang, Graciela Morales, John M. McLaughlin and Moe H. Kyaw
COVID 2023, 3(10), 1516-1527; https://doi.org/10.3390/covid3100103 - 23 Sep 2023
Cited by 8 | Viewed by 15193
Abstract
Vaccination against infectious disease affords direct protection from vaccine-induced immunity and additional indirect protection for unvaccinated persons. A systematic review was conducted to estimate the indirect effect of COVID-19 vaccination. From PubMed and Embase, 31 studies were included describing the impact of original [...] Read more.
Vaccination against infectious disease affords direct protection from vaccine-induced immunity and additional indirect protection for unvaccinated persons. A systematic review was conducted to estimate the indirect effect of COVID-19 vaccination. From PubMed and Embase, 31 studies were included describing the impact of original wild-type COVID-19 vaccines on disease transmission or viral load. Overall, study results showed the effectiveness of COVID-19 vaccination against SARS-CoV-2 transmission (range 16–95%), regardless of vaccine type or number of doses. The effect was apparent, but less pronounced against omicron (range 24–95% for pre-omicron variants versus 16–31% for omicron). Results from viral load studies were supportive, showing SARS-CoV-2 infections in vaccinated individuals had higher Ct values, suggesting lower viral load, compared to infections among the unvaccinated. Based on these findings, well-timed vaccination programs may help reduce SARS-CoV-2 transmission—even in the omicron era. Whether better-matched vaccines can improve effectiveness against transmission in the omicron era needs further study. Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop